Publication: Synthesis and Carbonic Anhydrase Inhibitory Properties of Novel Uracil Derivatives
| dc.authorscopusid | 8527557100 | |
| dc.authorscopusid | 6504284918 | |
| dc.authorscopusid | 23013520200 | |
| dc.authorscopusid | 23027537500 | |
| dc.contributor.author | Güney, M. | |
| dc.contributor.author | Çavdar, H. | |
| dc.contributor.author | Şentürk, M. | |
| dc.contributor.author | Ekinci, D. | |
| dc.date.accessioned | 2020-06-21T13:45:43Z | |
| dc.date.available | 2020-06-21T13:45:43Z | |
| dc.date.issued | 2015 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Güney] Murat, Department of Chemistry, Aǧrı İbrahim Çeçen Üniversitesi, Agri, Agri, Turkey; [Çavdar] Hüseyin, Faculty of Education, Dumlupinar Üniversitesi, Kutahya, Turkey; [Şentürk] Murat, Department of Chemistry, Aǧrı İbrahim Çeçen Üniversitesi, Agri, Agri, Turkey; [Ekinci] Deniz, Department of Agricultural Biotechnology, Ondokuz Mayis Üniversitesi, Samsun, Turkey | en_US |
| dc.description.abstract | Abstract Carbonic anhydrase (CA) inhibitors are valuable molecules based on several therapeutic applications, including antiglaucoma activity. In the present study, inhibition of two human cytosolic carbonic anhydrase isozymes I and II with some uracil derivatives (3-9) were investigated. Compounds 3-9 showed K<inf>I</inf> values in the range of 10.83-464 μM for hCA I and of 28.88-778.5 μM against hCA II, respectively. Kinetic investigations showed that similarly to classical CA inhibitors, all investigated natural compounds act as competitive inhibitors with 4-NPA as substrate. Uracil derivatives investigated here are promising agents which may be used as lead molecules in order to derivative novel carbonic anhydrase inhibitors that might be useful in medical applications. © 2015 Elsevier Ltd. | en_US |
| dc.identifier.doi | 10.1016/j.bmcl.2015.05.073 | |
| dc.identifier.endpage | 3263 | en_US |
| dc.identifier.issn | 1464-3405 | |
| dc.identifier.issue | 16 | en_US |
| dc.identifier.pmid | 26073005 | |
| dc.identifier.scopus | 2-s2.0-84934804445 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 3261 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2015.05.073 | |
| dc.identifier.volume | 25 | en_US |
| dc.identifier.wos | WOS:000357572000037 | |
| dc.identifier.wosquality | Q2 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Ltd | en_US |
| dc.relation.ispartof | Bioorganic & Medicinal Chemistry Letters | en_US |
| dc.relation.journal | Bioorganic & Medicinal Chemistry Letters | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Carbonic Anhydrase | en_US |
| dc.subject | Enzyme Inhibitor | en_US |
| dc.subject | Hydroxyl | en_US |
| dc.subject | Uracil | en_US |
| dc.title | Synthesis and Carbonic Anhydrase Inhibitory Properties of Novel Uracil Derivatives | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |